Literature DB >> 25039359

Monoclonal anti-A activity against the FORS1 (Forssman) antigen.

Katie Barr1, Elena Korchagina, Inna Popova, Nicolai Bovin, Stephen Henry.   

Abstract

BACKGROUND: The FORS blood group system (originally recognized as the Apae phenotype) was discovered by sporadic activity against polyclonal anti-A reagents and activity against the lectin Helix pomatia. The extent of monoclonal anti-A reagent activity against the FORS1 antigen is serologically and immunochemically incomplete. STUDY DESIGN AND METHODS: In the absence of natural FORS1-positive red blood cells (RBCs), kodecytes were created with synthetic disaccharide and pentasaccharide Forssman function-spacer-lipid (FSL) constructs, Fsdi -kodecytes, and FORS1-kodecytes, respectively. FSL constructs were also applied to solid surfaces and used in solid-phase enzyme immunoassays. A range of characterized monoclonal anti-A and anti-B reagents were then serologically and immunochemically characterized against these Forssman antigens. Polyclonal human anti-A, anti-B, the lectin H. pomatia serologic reagents; and canine RBCs were used as serologic controls.
RESULTS: None of 19 different monoclonal anti-A reagents were able to detect the pentasaccharide Forssman on FORS1-kodecytes, while three reagents were able to detect disaccharide Forssman on Fsdi -kodecytes. Most anti-A reagents were immunochemically reactive with both the di- and the pentasaccharide Forssman antigens in the solid-phase assays. Historic polyclonal human anti-A and the lectin H. pomatia reacted strongly with the FORS1-kodecytes, correlating with the discovery of the Apae phenotype and supporting the use of FORS1-kodecytes as FORS1 surrogates.
CONCLUSIONS: Monoclonal anti-A reagents, despite showing reactivity against the FORS1 antigen in solid-phase assays are unlikely to cause the agglutination of FORS1 antigen-positive RBCs.
© 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25039359     DOI: 10.1111/trf.12773

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  5 in total

1.  Diverse molecular recognition properties of blood group A binding monoclonal antibodies.

Authors:  Jeffrey C Gildersleeve; Whitney Shea Wright
Journal:  Glycobiology       Date:  2016-01-10       Impact factor: 4.313

2.  Prevalence of antibodies to a new histo-blood system: the FORS system.

Authors:  Carlos Jesus; Camilla Hesse; Clara Rocha; Nádia Osório; Ana Valado; Armando Caseiro; António Gabriel; Lola Svensson; Ali-Reza Moslemi; Wafa Abu Siba; Mahmoud A Srour; Cristina Pereira; Jorge Tomaz; Paulo Teixeira; Fernando Mendes
Journal:  Blood Transfus       Date:  2016-10-24       Impact factor: 3.443

3.  Expression of the GBGT1 Gene and the Forssman Antigen in Red Blood Cells in a Palestinian Population.

Authors:  Wafa Ali Abusibaa; Mahmoud A Srour; Ali-Reza Moslemi; Lola Svensson; Carlos Jesus; Fernando Mendes; Camilla Hesse
Journal:  Transfus Med Hemother       Date:  2019-03-29       Impact factor: 3.747

4.  Ultra-Fast Glyco-Coating of Non-Biological Surfaces.

Authors:  Eleanor Williams; Katie Barr; Elena Korchagina; Alexander Tuzikov; Stephen Henry; Nicolai Bovin
Journal:  Int J Mol Sci       Date:  2016-01-16       Impact factor: 5.923

5.  The Usefulness of Rare Blood Group Systems in the Risk Determination for Severe COVID-19.

Authors:  Theocharis G Konstantinidis; Valeria Iliadi; Georges Martinis; Maria Panopoulou
Journal:  Pathophysiology       Date:  2021-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.